Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain

Dan C Martin, R. P. Introna, R. S. Aronstam

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The influence of several opioid narcotics and related drugs, on the binding of [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin ([3H]8-OH-DPAT), a serotonergic agonist, to 5-HT1A receptors was determined in membranes from the brain of the rat. Sufentanil and fentanyl inhibited binding of [3H]8-OH-DPAT to hippocampal membranes, with IC50 values of 5.5 and 3.4 μM, respectively. In contrast, IC50 values for meperidine, alfentanil and naloxone exceeded 100 μM. The inhibition of binding by sufentanil appeared to be competitive insofar as 10 μM sufentanil increased the apparent KD from 1.0 ± 0.1 to 3.9 ± 0.3 nM, without affecting the number of binding sites and the inhibition was easily reversed. The binding of [3H]8-OH-DPAT to hippocampal membranes was inhibited by 5′-guanylylimidodiphosphate, a stable analogue of GTP, in a concentration-dependent manner. None of the opioid drugs examined altered the sensitivity of binding of [3H]8-OH-DPAT to guanine nucleotides. These results suggest that certain opioid narcotics, disrupt serotonergic neurotransmission as a result of direct interactions with 5-HT1A receptors. No effects of opioid narcotics on 5-HT1A receptor-G protein coupling were noted.

Original languageEnglish (US)
Pages (from-to)323-327
Number of pages5
JournalNeuropharmacology
Volume30
Issue number4
DOIs
StatePublished - Jan 1 1991

Fingerprint

Sufentanil
8-Hydroxy-2-(di-n-propylamino)tetralin
Receptor, Serotonin, 5-HT1A
Fentanyl
Opioid Analgesics
Narcotics
Membranes
Brain
Inhibitory Concentration 50
Alfentanil
Serotonin Receptor Agonists
Meperidine
Guanine Nucleotides
Naloxone
Guanosine Triphosphate
GTP-Binding Proteins
Synaptic Transmission
Pharmaceutical Preparations
Binding Sites
hydroxide ion

Keywords

  • 8-hydroxy-DPAT
  • G proteins
  • opioids
  • serotonergic receptors (5-HT receptors)
  • sufentanil

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. / Martin, Dan C; Introna, R. P.; Aronstam, R. S.

In: Neuropharmacology, Vol. 30, No. 4, 01.01.1991, p. 323-327.

Research output: Contribution to journalArticle

@article{e9739c89125f4bf5bda8b223f1e68765,
title = "Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain",
abstract = "The influence of several opioid narcotics and related drugs, on the binding of [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin ([3H]8-OH-DPAT), a serotonergic agonist, to 5-HT1A receptors was determined in membranes from the brain of the rat. Sufentanil and fentanyl inhibited binding of [3H]8-OH-DPAT to hippocampal membranes, with IC50 values of 5.5 and 3.4 μM, respectively. In contrast, IC50 values for meperidine, alfentanil and naloxone exceeded 100 μM. The inhibition of binding by sufentanil appeared to be competitive insofar as 10 μM sufentanil increased the apparent KD from 1.0 ± 0.1 to 3.9 ± 0.3 nM, without affecting the number of binding sites and the inhibition was easily reversed. The binding of [3H]8-OH-DPAT to hippocampal membranes was inhibited by 5′-guanylylimidodiphosphate, a stable analogue of GTP, in a concentration-dependent manner. None of the opioid drugs examined altered the sensitivity of binding of [3H]8-OH-DPAT to guanine nucleotides. These results suggest that certain opioid narcotics, disrupt serotonergic neurotransmission as a result of direct interactions with 5-HT1A receptors. No effects of opioid narcotics on 5-HT1A receptor-G protein coupling were noted.",
keywords = "8-hydroxy-DPAT, G proteins, opioids, serotonergic receptors (5-HT receptors), sufentanil",
author = "Martin, {Dan C} and Introna, {R. P.} and Aronstam, {R. S.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0028-3908(91)90056-H",
language = "English (US)",
volume = "30",
pages = "323--327",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain

AU - Martin, Dan C

AU - Introna, R. P.

AU - Aronstam, R. S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The influence of several opioid narcotics and related drugs, on the binding of [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin ([3H]8-OH-DPAT), a serotonergic agonist, to 5-HT1A receptors was determined in membranes from the brain of the rat. Sufentanil and fentanyl inhibited binding of [3H]8-OH-DPAT to hippocampal membranes, with IC50 values of 5.5 and 3.4 μM, respectively. In contrast, IC50 values for meperidine, alfentanil and naloxone exceeded 100 μM. The inhibition of binding by sufentanil appeared to be competitive insofar as 10 μM sufentanil increased the apparent KD from 1.0 ± 0.1 to 3.9 ± 0.3 nM, without affecting the number of binding sites and the inhibition was easily reversed. The binding of [3H]8-OH-DPAT to hippocampal membranes was inhibited by 5′-guanylylimidodiphosphate, a stable analogue of GTP, in a concentration-dependent manner. None of the opioid drugs examined altered the sensitivity of binding of [3H]8-OH-DPAT to guanine nucleotides. These results suggest that certain opioid narcotics, disrupt serotonergic neurotransmission as a result of direct interactions with 5-HT1A receptors. No effects of opioid narcotics on 5-HT1A receptor-G protein coupling were noted.

AB - The influence of several opioid narcotics and related drugs, on the binding of [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin ([3H]8-OH-DPAT), a serotonergic agonist, to 5-HT1A receptors was determined in membranes from the brain of the rat. Sufentanil and fentanyl inhibited binding of [3H]8-OH-DPAT to hippocampal membranes, with IC50 values of 5.5 and 3.4 μM, respectively. In contrast, IC50 values for meperidine, alfentanil and naloxone exceeded 100 μM. The inhibition of binding by sufentanil appeared to be competitive insofar as 10 μM sufentanil increased the apparent KD from 1.0 ± 0.1 to 3.9 ± 0.3 nM, without affecting the number of binding sites and the inhibition was easily reversed. The binding of [3H]8-OH-DPAT to hippocampal membranes was inhibited by 5′-guanylylimidodiphosphate, a stable analogue of GTP, in a concentration-dependent manner. None of the opioid drugs examined altered the sensitivity of binding of [3H]8-OH-DPAT to guanine nucleotides. These results suggest that certain opioid narcotics, disrupt serotonergic neurotransmission as a result of direct interactions with 5-HT1A receptors. No effects of opioid narcotics on 5-HT1A receptor-G protein coupling were noted.

KW - 8-hydroxy-DPAT

KW - G proteins

KW - opioids

KW - serotonergic receptors (5-HT receptors)

KW - sufentanil

UR - http://www.scopus.com/inward/record.url?scp=0025963171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025963171&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(91)90056-H

DO - 10.1016/0028-3908(91)90056-H

M3 - Article

VL - 30

SP - 323

EP - 327

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 4

ER -